Terms and Conditions for Patheon-Issued Purchase Orders

The following Terms & Conditions apply to all purchases made by Patheon entities within the respective country.

Australia

Terms & Conditions

Austria

Canada

France

Terms & Conditions

Germany

Ireland

Terms & Conditions

Italy

Terms & Conditions

The Netherlands

UK

Terms & Conditions

USA and Puerto Rico

Related Sites

Rheinfelden

Rheinfelden, DE

Pretoria, ZA

Pretoria, ZA

Mexico City, MX

Mexico City, MX

Vacaville, CA

Vacaville, CA

Rockville, MD

Rockville, MD

Frederick, MD

Frederick, MD

Franklin, MA

Franklin, MA

Indianapolis, IN

Indianapolis, IN

Bohemia, NY

Bohemia, NY

São Paulo, Brazil

São Paulo, BR

Santiago, Chile

Santiago, CL

Lima, Peru

Lima, PE

Bogotá, Colombia

Bogotá, CO

Weil am Rhein

Weil am Rhein, DE

Bishops Stortford, UK

Bishops Stortford, UK

Mount Prospect, Illinois

Mount Prospect, IL

Allentown, PA

Allentown, PA

Buenos Aires, Argentina

Buenos Aires, AR

Stevenage, UK

Stevenage, UK

Moscow, Russia

Moscow, RU

Horsham, UK

Horsham, UK

Basel, Switzerland

Basel, CH

Suzhou, China

Suzhou, CN (Free Trade Zone)

Tokyo, JP

Tokyo, JP

Singapore

Singapore

Seoul, Korea

Seoul, KR

Beijing, CN

Beijing, CN

Ahmedabad, IN (Domestic Tariff Area)

Ahmedabad, IN (Domestic Tariff Area)

Ahmedabad, IN (SEZ)

Ahmedabad, IN (Special Economic Zone)

Alachua, FL

Alachua, FL

Bend, OR

Bend, OR

Bourgoin, FR

Bourgoin, FR

Brisbane, AU

Brisbane, AU

Cambridge, MA

Cambridge, MA

Cincinnati, OH

Cincinnati, OH

Cork, Ireland

Cork, Ireland

Ferentino, IT

Ferentino, IT

Florence, SC (East)

Florence, SC (East)

Florence, SC (West)

Florence, SC (West)

Greenville, NC

Greenville, NC

Greenville, SC

Greenville, SC

Groningen, NL

Groningen, NL

High Point, NC

High Point, NC

Lexington, MA

Lexington, MA

Linz, AT

Linz, AT

Manatí, PR

Manatí, PR

Milton Park, UK

Milton Park, UK

Monza, IT

Monza, IT

Plainville, MA

Plainville, MA

Princeton, NJ

Princeton, NJ

Regensburg, DE

Regensburg, DE

St. Louis, MO

St. Louis, MO

Swindon, UK

Swindon, UK

Tilburg, NL

Tilburg, NL

Toronto, ON

Toronto, ON

Whitby, ON

Whitby, ON

Durham, NC

Durham, NC

Boston, MA

Boston, MA

Amsterdam Schiphol, NL

Amsterdam Schiphol, NL

Tokyo, JP

Tokyo, JP

Additional Resources

Enabling Fast And Appropriate Drug Product Supply For Phase 1 Clinical Trials

Benefits of 5KL Bioreactor When Outsourcing Late-phase Biologics Drug Substance Manufacturing

5 Ways Your Viral Vector Manufacturing Partner Should Make You Feel

Quantification of Vector Genomic DNA and Residual DNA in Gene Therapy Vectors Using ddPCR

Addressing the Complexity of Process Validation for Cell and Gene Therapy products

Understanding the CMC Regulatory Landscape for Cell and Gene Therapy Products

Practical Implementation of Innovative and Scalable Technologies to Accelerate Biologics Development and Commercialization: A CDMO Perspective

Saving Development Time with Single Vendor Approach

Evaluate Impact of Spray Drying Process Parameters and Equipment Type on the Granule Characteristic of the Immediate Release Tablets of a BCS (Biopharmaceutical Classification System) Class–IV Drug

Thinking Outside the Freezer: DNA and RNA Storage

Hot Melt Extrusion Process Optimization and Formulation Development of Amorphous Solid Dispersions for a Poorly Soluble Calcium Channel Blocker

Lyophilization: Small-Large Scale Comparability

To Determine the Dosing Disk and Encapsulation Speed for Encapsulation of a Drug Product Using Automated Encapsulator

A Quality by Design Approach to Optimize Tablet Formulations containing PVP VA64 Amorphous Dispersions: Formulation Variables

Discrete Element Modeling of a Pharmaceutical Blending Process

Accelerated stability assessment for an oral N-type calcium channel blocker

Evaluation of a Quality by Design (QbD) Approach for Process Development and Scale-Up of a Novel ALS Drug Product

Enhanced Solubilization of an Analgesic/Antipyretic Drug With The Use of Polymeric Excipients

Controlled Release of an OTC Cough Suppressant in a Soft Gelatin Based Dosage Form

Comparative PK Performance of Solution and Suspension Based Formulations For a BCS Class II Molecule in a Soft Gelatin Based Dosage Form

Development of a High Shear Wet Granulation Process Through the Use of Design of Experiments

Shortening The Timeline To First In Human (FIH) Clinical Dosage Form For Oral/Injectable Delivery

Does Your Clinical Trial Design Satisfy the Needs of your Patients

Leveraging Infrastructure Investments and Innovation to Accelerate Biologics Development

Addressing Technical Challenges in Development Drug Products: A CDMO Perspective

Investigator Initiated Trial (IIT) Service for Pharma Companies

Total Transportation Management for the Life Science Industry Fact Sheet

Investigator Initiated Trial (IIT)Service for Institutions Fact Sheet

Reusable Shipper Program Fact Sheet

Qualified Person (QP) Services Fact Sheet

Pre-Filled Syringe Fact Sheet

Global Logistics Help Desk

Global Label Services Fact Sheet

Comparator and Co-Medication Sourcing Services Fact Sheet

Cold Chain Management & Mindset

Clinical Supply Optimization Services Fact Sheet

Clinical Ancillary Management Fact Sheet

How a Best-Practice Strategy for Sourcing Ancillary Materials Reduced Risk, Spending and Workload in a Global Diabetes Trial

Conventional vs. Unconventional Spray Drying Strategies: Development to Commercialization

Accelerating Cell Culture Development through Practical Application of Innovation Technologies

Technology Transfers Best Practices for Optimizing Success and Mitigating Risk

Leveraging Innovative Technologies, Best Practices and Strategies to Accelerate Biologics Development and Commercialization

Factoring the "What Ifs" into Supply Forecasting

Using Quality By Design For Process Development And Scale-Up Of A Novel ALS Drug Product

Clinical Supply Global Optimization

CMO Scorecard Trend Report

Continuous Monitoring Solutions for Cold Chain Logistics

Transportation Solutions for Cell and Gene Therapy Supply Chains

Key Considerations for Labeling Your Cell or Gene Therapy

Cold Chain Shipping Considerations

Clinical Trial Supply Solutions

Direct-to-Patient Pharmacy Services Overview

Depot-to-Patient Service Infographic

Solved With: Direct-to-Patient Services

Challenges and Practical Solutions for Switching to Prefilled Syringes for Injectables

Total Transportation Management for the Life Sciences Industry

Quick to Care™: Integrated Drug Development and Clinical Services for New and Emerging Pharma

Quick to Clinic™ for Oral Solid Dose

Pharma Services Global Network: Capabilities and Locations to Support Your Every Milestone

Sample Fulfillment & Distribution

API (Small Molecule) Overview

Biologics Overview

Early Development Fact Sheet

Quick to Clinic™ Delivers Phase I Clinical Trial Material, Fast

OnTheGo℠ Suite of Services

Softgel Technologies

Specialty Courier Services Overview

Preferred Carrier Management

Commercial Packaging Overview Brochure

Continuous Manufacturing: The Alternative to Batch Manufacturing

Quadrant 2 ®: Predictive Platform for Solubility and Bioavailability Enhancement

ATLAS (Alternative Translation and Label Approval System)

Crystallization and Solid State Chemistry Overview

Viral Vector Services Regulatory Offering

Fill / Finish Services for Viral Vectors

Cell & Gene Therapy Solutions

Infographic: 10 Ways to Derail Your Clinical Trial

10 Steps that Risk Failure in the Temperature Controlled Clinical Supply Chain

5 Big Common Missteps in Comparator Sourcing

Infographic: A Tale of Two Molecules

Infographic: 8 Criteria for a More Successful API Partnership

Cold Chain Qualification: 5 Questions You Must Ask

Common Softgel Myths Debunked

Cell Therapy Logistics: Advanced Therapy

Total Transportation Management Saves Company $10.2M

Clinical Supply Optimization

The Critical Importance of Comparator Temperature Excursion Management

Post Pandemic Planning: What will change in the clinical supply chain?

Webinar: Post Pandemic Planning: What Will Change in Early-Phase Drug Development?

Ancillary Supplies: Clinical Trial "Must-Haves" that Require Early Planning

Automation Slashes Turnaround Time for Clinical Trial Labeling

Early Licensure of a Breakthrough Cancer Drug Gives Hope to Patients

Cold Chain Reuseable Shippers Reduces Risk and Waste

Managing Clinical Ancillary Supplies at Global Scale

Clinical Trial Packaging: Smart Choices can Trim Timelines

High Precision Syringe Labeling

Clinical Packaging Process Overhaul Cuts Cycle Time by 55%

Blister Pack Design Considerations

Broad Thinking Yields Big Results

Not Just A Vendor, But Part Of The Team

How to Select the Best Courier Around the Globe

Solutions for Oncology Studies

Clinical Trial Packaging Solutions: Balancing Cost, Time and Quality

Total Transportation Management: Your Guide to On-Time, In-Full Deliveries

Top 5 Questions Asked About Pre-Filled Syringes

Keep Your Clinical Trial on Track

Clinical Trial Packaging: Innovative, Flexible and Time-Sensitive Solutions

Using an Approved Phrase Library

Importer of Record Frequently Asked Questions

The Challenge of Keeping Cool: End-to-End Temperature Management for the Clinical Chain Supply

Managing Temperature Excursions

Evaluating and Qualifying Temperature Managed Shippers

Cold Chain Shipping Considerations

Cold Chain Industry Trends

Reasons for Building an Approved Phrase Library

Taking a Strategic Approach to Comparator Drug Sourcing

Comparator Local Sourcing for Clinical Trials

Ukraine & Russia: Opportunities and Challenges for Clinical Research

Comparator Local Sourcing Strategies

Clinical Trial Supply Solutions

Safely Transporting Medicines to Patient: De-Risking the Supply Chain

Challenges and Practical Solutions for Changing Over to Pre-filled Syringes for Parenteral Drug

Smooth Transition: What Specialty Drug Manufacturers Should Know About Bridging the Gap from Clinical-to-Commercial Packaging

Your Clinical Results Look Promising, but are You Ready for Launch? How to Build a Robust Packaging Strategy for Rapid Commercialization

Leading Viral Vector CDMO Services for Cell and Gene Therapies

Bulletproofing Your Supply Chain: Hope for the Best, Prepare for the Worst

Continuous Manufacturing: Drug Development Workflow and Benefits

Drug Repurposing Trends—A CDMO Perspective

Critical API Attributes and the Major Impact They Can Have on Drug Product Development

What You Need to Know About Process Characterization and Validation For Biologic Processes

Continuous or Batch: Deciding on the Best Solution for your Oral Solid Dose Product

Telltale Signs You're with the Wrong CDMO

COVID-19 Threatens Pharma’s Global Supply Chain. What Next?

Challenge Accepted: Biopharma Puts COVID-19 in Its Pipeline

Innovative Solutions to Bring Medicines to Patients Faster

Satisfying Aggressive Timelines With a Simplified Supply Chain for Drug Delivery

Driving Supply Chain Productivity in Cell Therapy Clinical Trials

Transportation Solutions for Cell and Gene Therapy

Spray Drying Processability of Methacrylic Acid Copolymers in Amorphous Dispersions: A QbD Approach

Softgel Technologies Overview

Choosing the Right CDMO for Late Phase Clinical Trials

Process Characterization: Ready For The FDA?

Kaleido Biosciences Successfully Meets Aggressive IND Filing Date Thanks to Strategic Partnership

Flexibility Enables Managing Large Leaflet on Automatic Packaging Line

Identifying and Solving Scale-up Challenges in the Synthesis and Formulation of Small-Molecule APIs

Biopharma Capabilities Overview

Quick to Clinic for Oral Solid Dose

Meeting Milestones and Patient Needs Through Expedited Delivery of Phase I Materials

The Criticality of API CDMO Selection: Insights from a Client

Global Ultra-Cold Clinical Trial Logistics

Expedited Import of Zika Virus Test Kits Enable Vital Research

Delivering Clinical Trial Medications Direct-to-Patient

How Pacira Pharma Is Working To Help Curb The Opioid Epidemic

Direct to Representative Sample Distribution Services

Cost Savings and Speed: The Untapped Value of a Single-Source Solution

Collegium Pharmaceutical’s Approach to Abuse Deterrence Breaks New Ground

Fighting The Opioid Epidemic: How Grünenthal’s Abuse-Deterrent Technology Contributes

Why are Lipid Formulations Commonly Used to Enhance Bioavailability?

Flow Chemistry: A Scale-Up Solution For Modern API Development & Manufacturing

Ensuring the Greatest Return From Your Poorly Soluble Molecule

Strategies for API Solubility and Bioavailability Enhancement

Flexible Solutions to Speed Your Molecules to Phase I Clinical Trials

The Pharma Trends You Need to Know: A CDMO’s Perspective

Pharma Services Overview Brochure

Why Did Thermo Fisher Scientific Acquire Patheon?

How Well Should You Understand Your Crystallization Process (and Solid-State Properties)?

How Well Should You Understand Your Crystallization Process (and Solid-State Properties)?

Six API Challenges That Could Be Slowing Your Development and How to Avoid Them

In-House Versus Outsource: A Decision-Making Guide

Quality by Design: A Holistic Approach to Drug Development

Getting to First-in-Human Clinical Trials: A Make-or-Break Milestone for Small Biopharmas

Phase-Appropriate Formulation Development & Manufacturing for Parenteral Dosage Forms

Choosing the Best Sterile Dosage Form for Your Phase I Clinical Supply Needs

Rise in Targeted Therapies Drives Need for Small-Volume Manufacturing

Are You Prepared for the Complexity of Pediatric Drug Development?

Novel Uses for Oral Solid Doses Driving Lifecycle Management Strategies

Accelerate Complex Molecule Development by Optimizing Chemical Synthesis and Formulation

Synthesizing Success: Six Principles for Getting Pharmaceutical Development Right from the Start

Implications of Inaccurate Forecasting on Biologics Drug Substance Manufacturing

Biologics Overview: Flexible Biomanufacturing Solutions

The Economic Advantage of Single-Source Drug Development and Manufacturing

So Many Choices: What’s the Right Biomanufacturing Strategy for Me?

Challenges in the Development of Complex Small-Molecule Drugs

What You Need to Know to Avoid Costly Delays in Your API Scale-Up

Case Study: Curbing the Opioid Epidemic with Pacira Pharmaceuticals

Ensure the Scalability of Your Molecule with a Science-Driven, Phase-Appropriate Approach

Choosing the Best Biomanufacturing Strategy: The Value of a Multi-Pronged Approach

The Race to Phase III: A Cautionary Tale of Scalability

How Can You Avoid the Fallout From Incompatibility Between Your API and Its Formulation?

Characterizing Drug Substance Properties Early Can Optimize Drug Product Formulation

Technology Transfers: Reaping Rewards, Reducing Risks

Decision Timeline: Considerations in Selecting an Outsourced Solution

Is Your In-House Strategy Ready for the Uncertainties of Biologic Drug Development?

Managing Demand Uncertainty in Biologics Production

Avoid the Do-Over: Why Early Investment in a Scalable Manufacturing Process Is Critical

Anticipating the Formulation Challenges of Complex Molecules

How Adaptable Manufacturing Models are Paving a Steady Path into an Unpredictable Future

Trends and Challenges in Outsourced Oral Solid Dosage Forms

Top 5 Considerations When Looking to Outsource to a Biomanufacturing Partner

The Right Partner Can Improve Flexibility and Mitigate Risks from Forecast Inaccuracy in Biomanufacturing

Consultants’ Guide to Flexible Biomanufacturing Solutions

Top Five Risks Facing Your Small Biopharma Clients Today

Challenges, Risks, and Strategies for Biologic Substance Manufacturing

Challenges and Solutions in Cytotoxins and HPAPIs

Anticipating the Formulation Challenges of Complex Molecules

Phase Appropriate Formulation and Process Design

Solving the OOS Problem with Continuous Manufacturing

Impact of Incorrect Forecasts on New Product Launches

Solutions to Today’s Biomanufacturing Challenges

Tightening The Supply Chain: Patheon Aims to Transform Pharma Outsource Manufacturing

What to Look For in a Solubility Enhancement Vendor

Amorphous Dispersion Drug Formulations: A Modern Simulation-Based Approach

Multiplexing: Managing Risk with Proven, Single-Use Solutions

The Advantages of Employing a Lipid-Based Formulation Process in Early Development

Executive Research: Impact of Incorrect Forecasts on New Product Launches

Early Stage Development for Solid Dose Products

Built To Fail: How Today's Manufacturing Options Leave Pharma At Risk

How Broadening the Analysis of Compound Factors Allows for Predictive Solubility Solutions

Taking An Informed Approach To Technology Selection To Address Solubility Challenges In Early Development

Taking a More Informed Approach to Solubility Enhancement